Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
The ATTAIN-MAINTAIN Phase 3b trial, published in Nature Medicine on May 13, 2026, demonstrates that the oral nonpeptide GLP-1 receptor agonist orforglipron effectively maintains weight loss and cardiometabolic improvements in ... Read More
Continuous Coverage
Picture this: a fleet of Spirit Airlines jets, stripped of their livery, parked nose-to-tail in the Arizona desert…
Warren G. Harding’s FIRST Robotics Team ELITE—an all-star squad of high school engineers—just crushed it at the 2026…
Sleep apnea—a disorder where breathing repeatedly stops and starts during sleep—may have a stronger genetic link than previously…
Universal Music Group is betting big on streaming stability, reporting a resilient first quarter—even as the music industry’s…
Mamelodi Sundowns face AS FAR in the CAF Champions League final first leg at Loftus Versfeld on Sunday,…
Researchers have decoded a complex mathematical algorithm within the leaf structures of the Pilea peperomioides, revealing how natural…
Global Affairs
Chinese President Xi Jinping has framed Taiwan as the “most critical issue” in U.S.-China relations during a high-stakes…
Markets And Money
Samsung Electronics (KRX: 005930) faces a potential strike by 50,000 workers over wage disputes, threatening to disrupt the…
Digital Culture
A German court has ruled that Milka’s advertising for its chocolate products was misleading to consumers, marking a…
Science And Wellbeing
Researchers have developed an implanted bioartificial device designed to house insulin-producing islet cells, potentially offering long-term glucose regulation…
Screen And Sound
Rīga’s City Council is allocating nearly €100,000 in public funds to secure international music stars for local performances.…
Fixtures And Form
Real Madrid’s election for president and board of directors, triggered by Florentino Pérez’s refusal to resign despite mounting…
